Jump to content

Carol Prives: Difference between revisions

Add links
From Wikipedia, the free encyclopedia
Browse history interactively
← Previous edit
Content deleted Content added
VisualWikitext
Added links to SV40 DNA, gene expression and oncogenic. Added in honorary doctorate information.
 
(17 intermediate revisions by 13 users not shown)
Line 32: Line 32:
| children =
| children =
}}
}}
{{In use}}
'''Professor Carol L. Prives''' [[Fellow of the Royal Society|FRS]] is the Da Costa Professor of Biological Sciences at [[Columbia University]].<ref name="aacrcanada.ca">{{cite web|url=http://www.aacrcanada.ca/Pages/Carol-Prives-Bio.aspx|title=Carol L. Prives, PhD - AACR International|website=www.aacrcanada.ca}}</ref>
'''Professor Carol L. Prives''' [[Fellow of the Royal Society|FRS]] is the Da Costa Professor of Biological Sciences at [[Columbia University]].<ref name="aacrcanada.ca">{{cite web|url=http://www.aacrcanada.ca/Pages/Carol-Prives-Bio.aspx|title=Carol L. Prives, PhD - AACR International|website=www.aacrcanada.ca}}</ref>
She is known for her work in the characterisation of [[p53]], an important tumor suppressor protein frequently mutated in cancer.
She is known for her work in the characterisation of [[p53]], an important tumor suppressor protein frequently mutated in cancer.


== Education ==
== Education ==
Prives was educated in Canada, received her BSc and PhD<ref>{{Cite web|last=Prives|first=Carole|others=C. (Supervisor) Sung|title=The biosynthesis of nucleotides and nucleic acis in Ehrlich ascites cells and the effect of colchicine thereon.|url=https://escholarship.mcgill.ca/concern/theses/8049g834t|access-date=2020-08-16|website=escholarship.mcgill.ca}}</ref> in 1966<ref name="aacr" /> from [[McGill University]], undertaking research in the lab of [[Juda Hirsch Quastel]].<ref>{{cite web|url=https://www.bloomberg.com/research/stocks/private/person.asp?personId=9778640&privcapId=121265|title=Carol L. Prives Ph.D.: Executive Profile & Biography - Bloomberg |website=www.bloomberg.com}}</ref> She pursued postdoctoral fellowships at [[Albert Einstein College of Medicine]] and the [[Weizmann Institute]] under the mentorship of Professor [[Professor Michel Revel|Michel Revel]]. after which she became a faculty member at the Weizmann Institute.<ref name="aacrcanada.ca" /> She received an honorary Doctor of Sciences degree from McGill University, her alma mater, on 29 May 2014 for her contributions to the understanding of p53.<ref>{{Cite web|last=Phone: 514 398-6751|first=Contact Information Contact: Julie Fortier Organization: Media Relations Office Email: julie c fortiermcgill ca Office|title=14 individuals to receive honorary degree from McGill|url=https://www.mcgill.ca/newsroom/channels/news/14-individuals-receive-honorary-degree-mcgill-235514|access-date=2020-08-16|website=Newsroom|language=en}}</ref>
Prives was educated in Canada, received her BSc and PhD<ref>{{Cite web|last=Prives|first=Carole|others=C. (Supervisor) Sung|title=The biosynthesis of nucleotides and nucleic acis in Ehrlich ascites cells and the effect of colchicine thereon.|url=https://escholarship.mcgill.ca/concern/theses/8049g834t|access-date=2020-08-16|website=escholarship.mcgill.ca}}</ref> in 1966<ref name="aacr" /> from [[McGill University]], undertaking research in the lab of [[Juda Hirsch Quastel]].<ref>{{cite web|url=https://www.bloomberg.com/research/stocks/private/person.asp?personId=9778640&privcapId=121265|title=Carol L. Prives Ph.D.: Executive Profile & Biography - Bloomberg |website=www.bloomberg.com|date=28 September 2023 }}</ref> She pursued postdoctoral fellowships at [[Albert Einstein College of Medicine]] and the [[Weizmann Institute]] under the mentorship of Professor [[Professor Michel Revel|Michel Revel]]. after which she became a faculty member at the Weizmann Institute.<ref name="aacrcanada.ca" /> She received an honorary Doctor of Sciences degree from McGill University, her alma mater, on 29 May 2014 for her contributions to the understanding of p53.<ref>{{Cite web|last=Phone: 514 398-6751|first=Contact Information Contact: Julie Fortier Organization: Media Relations Office Email: julie c fortiermcgill ca Office|title=14 individuals to receive honorary degree from McGill|url=https://www.mcgill.ca/newsroom/channels/news/14-individuals-receive-honorary-degree-mcgill-235514|access-date=2020-08-16|website=Newsroom|language=en}}</ref>


== Research and career ==
== Research and career ==
In 1995, she was appointed as the Da Costa Professor of Biology at [[Columbia University]].<ref name=aacr/> She was the chair of the Department of Biological Sciences from 2000 to 2004.<ref name=weiz/>
In 1995, she was appointed as the Da Costa Professor of Biology at [[Columbia University]].<ref name=aacr/> She was the chair of the Department of Biological Sciences from 2000 to 2004.<ref name=weiz/>


Her early interest in the [[SV40|SV40 DNA tumour virus]] as a model for eukaryotic [[gene expression]] and [[Oncogenic virus|oncogenic]] transformation led her to the study of p53.<ref>{{Cite web|title=Carol Prives|url=http://www.nasonline.org/member-directory/members/20011492.html|access-date=2020-08-16|website=www.nasonline.org}}</ref> Since the late 1980s, her lab has focused on the [[p53]] tumour suppressor gene, one of the most frequently mutated in human cancers.
Her early interest in the [[SV40|SV40 DNA tumour virus]] as a model for eukaryotic [[gene expression]] and [[Oncogenic virus|oncogenic]] transformation led her to the study of p53.<ref>{{Cite web|title=Carol Prives|url=http://www.nasonline.org/member-directory/members/20011492.html|access-date=2020-08-16|website=www.nasonline.org}}</ref> Since the late 1980s, her lab has focused on the [[p53]] tumour suppressor gene, one of the most frequently mutated in human cancers.


Prives has served as chair of the Experimental Virology and the Cell and Molecular Pathology study sections of the [[National Institutes of Health]]. She has been a member of the Scientific Advisory Boards of the [[Dana–Farber Cancer Institute]], the [[Memorial Sloan Kettering Cancer Center]], the Massachusetts General Cancer Center, the [[National Cancer Institute]],<ref name="aacrcanada.ca" /> and the [[Weizmann Institute]].<ref name="weiz">{{cite web |title=Prof. Carol Prives {{!}} International Board 2018 |url=http://www.weizmann.ac.il/conferences/InternationalBoard2018/prof-carol-prives |website=www.weizmann.ac.il |accessdate=3 May 2019}}</ref> She was a member of the board of directors of the [[American Association for Cancer Research]] from 2004 to 2007.
Prives has served as chair of the Experimental Virology and the Cell and Molecular Pathology study sections of the [[National Institutes of Health]]. She has been a member of the Scientific Advisory Boards of the [[Dana–Farber Cancer Institute]], the [[Memorial Sloan Kettering Cancer Center]], the Massachusetts General Cancer Center, the [[National Cancer Institute]],<ref name="aacrcanada.ca" /> and the [[Weizmann Institute]].<ref name="weiz">{{cite web |title=Prof. Carol Prives {{!}} International Board 2018 |url=http://www.weizmann.ac.il/conferences/InternationalBoard2018/prof-carol-prives |website=www.weizmann.ac.il |accessdate=3 May 2019}}</ref> She was a member of the board of directors of the [[American Association for Cancer Research]] from 2004 to 2007. She also served on the Life Sciences jury for the [[Infosys Prize]] in 2010.


She is a member of the editorial boards of ''[[Cell (journal)|Cell]]'',<ref>https://www.cell.com/cell/editorial-board</ref> ''[[Oncogene (journal)|Oncogene]]''<ref>{{cite web|url=https://www.nature.com/onc/editors/editorial-board|title=Editorial Board - Oncogene|website=www.nature.com}}</ref> and the ''[[Proceedings of the National Academy of Sciences]]''.<ref>{{cite web |title=PNAS Member Editor Details |url=https://nrc88.nas.edu/pnas_search/memberDetails.aspx?ctID=20011492 |website=nrc88.nas.edu |accessdate=3 May 2019}}</ref>
She is a member of the editorial boards of ''[[Cell (journal)|Cell]]'',<ref>{{Cite web|url=https://www.cell.com/cell/editorial-board|title = Editorial board: Cell}}</ref> ''[[Oncogene (journal)|Oncogene]]''<ref>{{cite web|url=https://www.nature.com/onc/editors/editorial-board|title=Editorial Board - Oncogene|website=www.nature.com}}</ref> and the ''[[Proceedings of the National Academy of Sciences]]''.<ref>{{cite web |title=PNAS Member Editor Details |url=https://nrc88.nas.edu/pnas_search/memberDetails.aspx?ctID=20011492 |website=nrc88.nas.edu |accessdate=3 May 2019}}</ref>


== Awards ==
== Awards ==
Line 53: Line 52:
* 2001 Elected Fellow, [[American Academy of Microbiology]]
* 2001 Elected Fellow, [[American Academy of Microbiology]]
* 2005 Elected Member, [[Institute of Medicine]]
* 2005 Elected Member, [[Institute of Medicine]]
* 2008 Elected Member, [[National Academy of Sciences]]<ref>{{cite web|url=http://www.nasonline.org/member-directory/members/20011492.html|title=Carol Prives|first=National Academy of Sciences -|last=http://www.nasonline.org|website=www.nasonline.org}}</ref>
* 2008 Elected Member, [[National Academy of Sciences]]<ref>{{cite web|url=http://www.nasonline.org/member-directory/members/20011492.html|title=Carol Prives|website=www.nasonline.org}}</ref>
* 2009 Rosalind E. Franklin Award for Women in Science<ref>{{Cite web|date=2017-02-06|title=Past Winners of the NCI Rosalind E. Franklin Award - National Cancer Institute|url=https://dceg.cancer.gov/fellowship-training/training-resources-for-fellows-and-staff/rosalind-franklin-award|access-date=2020-08-16|website=dceg.cancer.gov|language=en}}</ref>, [[National Cancer Institute]]
* 2009 Rosalind E. Franklin Award for Women in Science,<ref>{{Cite web|date=2017-02-06|title=Past Winners of the NCI Rosalind E. Franklin Award - National Cancer Institute|url=https://dceg.cancer.gov/fellowship-training/training-resources-for-fellows-and-staff/rosalind-franklin-award|access-date=2020-08-16|website=dceg.cancer.gov|language=en}}</ref> [[National Cancer Institute]]
* 2010 [[Dr. Paul Janssen Award for Biomedical Research|Paul Janssen Prize in Biotechnology and Medicine]], Center for Advanced Biotechnology and Medicine
* 2010 [[Dr. Paul Janssen Award for Biomedical Research|Paul Janssen Prize in Biotechnology and Medicine]], Center for Advanced Biotechnology and Medicine
* 2011 AACR-Women in Cancer Research Charlotte Friend Memorial Lectureship<ref name=aacr>{{cite web|url=http://www.aacr.org:80/Membership/Pages/FellowDetailsNoModal.aspx?ItemID=154|title=Carol L. Prives, PhD|publisher=}}</ref>
* 2011 AACR-Women in Cancer Research Charlotte Friend Memorial Lectureship<ref name=aacr>{{cite web|url=http://www.aacr.org:80/Membership/Pages/FellowDetailsNoModal.aspx?ItemID=154|title=Carol L. Prives, PhD|publisher=}}</ref>
* 2015 Elected Fellow, [[AACR Academy]]<ref name=aacr/>
* 2015 Elected Fellow, [[AACR Academy]]<ref name=aacr/>
* 2020 Elected Fellow, [[The Royal Society]]<ref>{{cite web|url=https://royalsociety.org/people/Carol-Prives-25386/|title=Carol Prives FRS, Royal Society}}</ref>
* 2020 Elected Fellow, [[The Royal Society]]<ref>{{cite web|url=https://royalsociety.org/people/Carol-Prives-25386/|title=Carol Prives FRS, Royal Society}}</ref>
* 2021 Recipient of AACR-G.H.A. Clowes Award for Outstanding Basic Cancer Research


== References ==
== References ==
Line 68: Line 68:
[[Category:Year of birth missing (living people)]]
[[Category:Year of birth missing (living people)]]
[[Category:Living people]]
[[Category:Living people]]
⚫
[[Category:Canadian scientists]]
[[Category:Fellows of the AACR Academy]]
[[Category:Fellows of the AACR Academy]]
[[Category:Columbia University faculty]]
[[Category:Columbia University faculty]]
[[Category:McGill University alumni]]
[[Category:McGill University alumni]]
[[Category:Canadian women scientists]]
[[Category:Canadian women biologists]]
[[Category:Canadian biologists]]
[[Category:20th-century Canadian biologists]]
[[Category:20th-century Canadian scientists]]
[[Category:21st-century Canadian biologists]]
⚫
[[Category:21st-century Canadian scientists]]
[[Category:Albert Einstein College of Medicine alumni]]
[[Category:Albert Einstein College of Medicine alumni]]
[[Category:20th-century American scientists]]
[[Category:20th-century American biologists]]
[[Category:21st-century American scientists]]
[[Category:21st-century American women scientists]]
[[Category:American women scientists]]
[[Category:20th-century American women scientists]]
[[Category:21st-century American biologists]]
[[Category:21st-century American biologists]]
[[Category:Scientists from New York City]]
[[Category:Scientists from New York City]]
[[Category:Female fellows of the Royal Society]]
[[Category:American women academics]]
⚫
[[Category:20th-century Canadian women scientists]]
⚫
[[Category:21st-century Canadian women scientists]]
[[Category:Canadian fellows of the Royal Society]]
[[Category:Members of the National Academy of Medicine]]

Latest revision as of 08:30, 13 September 2024

Carol Prives
EducationBSc McGill University, Canada

PhD McGill University, Canada

Honorary Doctor of Sciences McGill University, Canada
Alma mater
Known forThe characterization of p53, an important tumour suppressor protein frequently mutated in cancer.
AwardsNIH MERIT Award (1996)

Rosalind E. Franklin Award for Women in Science, National Cancer Institute (2009)

Paul Janssen Prize in Biotechnology and Medicine (2010)

AACR-Women in Cancer Research Charlotte Friend Memorial Lectureship (2011)
Scientific career
Institutions

Professor Carol L. Prives FRS is the Da Costa Professor of Biological Sciences at Columbia University.[1] She is known for her work in the characterisation of p53, an important tumor suppressor protein frequently mutated in cancer.

Education

[edit]

Prives was educated in Canada, received her BSc and PhD[2] in 1966[3] from McGill University, undertaking research in the lab of Juda Hirsch Quastel.[4] She pursued postdoctoral fellowships at Albert Einstein College of Medicine and the Weizmann Institute under the mentorship of Professor Michel Revel. after which she became a faculty member at the Weizmann Institute.[1] She received an honorary Doctor of Sciences degree from McGill University, her alma mater, on 29 May 2014 for her contributions to the understanding of p53.[5]

Research and career

[edit]

In 1995, she was appointed as the Da Costa Professor of Biology at Columbia University.[3] She was the chair of the Department of Biological Sciences from 2000 to 2004.[6]

Her early interest in the SV40 DNA tumour virus as a model for eukaryotic gene expression and oncogenic transformation led her to the study of p53.[7] Since the late 1980s, her lab has focused on the p53 tumour suppressor gene, one of the most frequently mutated in human cancers.

Prives has served as chair of the Experimental Virology and the Cell and Molecular Pathology study sections of the National Institutes of Health. She has been a member of the Scientific Advisory Boards of the Dana–Farber Cancer Institute, the Memorial Sloan Kettering Cancer Center, the Massachusetts General Cancer Center, the National Cancer Institute,[1] and the Weizmann Institute.[6] She was a member of the board of directors of the American Association for Cancer Research from 2004 to 2007. She also served on the Life Sciences jury for the Infosys Prize in 2010.

She is a member of the editorial boards of Cell,[8] Oncogene[9] and the Proceedings of the National Academy of Sciences.[10]

Awards

[edit]

References

[edit]
  1. ^ a b c "Carol L. Prives, PhD - AACR International". www.aacrcanada.ca.
  2. ^ Prives, Carole. "The biosynthesis of nucleotides and nucleic acis in Ehrlich ascites cells and the effect of colchicine thereon". escholarship.mcgill.ca. C. (Supervisor) Sung. Retrieved 2020-08-16.
  3. ^ a b c d "Carol L. Prives, PhD".
  4. ^ "Carol L. Prives Ph.D.: Executive Profile & Biography - Bloomberg". www.bloomberg.com. 28 September 2023.
  5. ^ Phone: 514 398-6751, Contact Information Contact: Julie Fortier Organization: Media Relations Office Email: julie c fortiermcgill ca Office. "14 individuals to receive honorary degree from McGill". Newsroom. Retrieved 2020-08-16. {{cite web}}: |first= has generic name (help)CS1 maint: numeric names: authors list (link)
  6. ^ a b "Prof. Carol Prives | International Board 2018". www.weizmann.ac.il. Retrieved 3 May 2019.
  7. ^ "Carol Prives". www.nasonline.org. Retrieved 2020-08-16.
  8. ^ "Editorial board: Cell".
  9. ^ "Editorial Board - Oncogene". www.nature.com.
  10. ^ "PNAS Member Editor Details". nrc88.nas.edu. Retrieved 3 May 2019.
  11. ^ "Carol Prives". www.nasonline.org.
  12. ^ "Past Winners of the NCI Rosalind E. Franklin Award - National Cancer Institute". dceg.cancer.gov. 2017-02-06. Retrieved 2020-08-16.
  13. ^ "Carol Prives FRS, Royal Society".
Retrieved from "https://en.wikipedia.org/enwiki/w/index.php?title=Carol_Prives&oldid=1245490498"